McKinsey to pay $650m to settle opioid charges

The company “knowingly and intentionally” conspired with pharmaceutical firm Purdue Pharma to “aid and abet the misbranding of prescription drugs… without valid prescriptions”, according to the US Department of Justice.

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Related Posts